Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 1.72% | 0.01% |
| 1-Month Return | 17.27% | 3.54% |
| 3-Month Return | 22.49% | 10.58% |
| 6-Month Return | 23.07% | 8.03% |
| 1-Year Return | 60.77% | 20.06% |
| 3-Year Return | 68.28% | 70.98% |
| 5-Year Return | 31.65% | 71.89% |
| 10-Year Return | 56.33% | 252.66% |
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 143.33% | 0.52% |
| 1-Month Return | 594.66% | 52.69% |
| 3-Month Return | 127.67% | 50.36% |
| 6-Month Return | 52.34% | 16.96% |
| 1-Year Return | 60.77% | 20.06% |
| 3-Year Return | 18.94% | 19.58% |
| 5-Year Return | 5.65% | 11.44% |
| 10-Year Return | 4.57% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
CRINETICS PHARMACEUTICALS IN | CRNX | 3.53% |
MBX BIOSCIENCES INC | MBX | 3.07% |
DEFINIUM THERAPEUTICS INC | DFTX | 3.02% |
ALUMIS INC | ALMS | 2.19% |
EDGEWISE THERAPEUTICS INC | EWTX | 2.13% |
ENLIVEN THERAPEUTICS INC | ELVN | 2.04% |
ATAIBECKLEY INC | ATAI | 2.04% |
TREVI THERAPEUTICS INC | TRVI | 1.99% |
AMYLYX PHARMACEUTICALS INC | AMLX | 1.98% |
VERADERMICS INC | MANE | 1.94% |
NUVATION BIO INC | NUVB | 1.93% |
MAZE THERAPEUTICS INC | MAZE | 1.91% |
LIGAND PHARMACEUTICALS | LGND | 1.88% |
NEKTAR THERAPEUTICS | NKTR | 1.86% |
LIQUIDIA CORP | LQDA | 1.81% |
OCULAR THERAPEUTIX INC | OCUL | 1.75% |
EYEPOINT INC | EYPT | 1.74% |
HARROW INC | HROW | 1.73% |
CORCEPT THERAPEUTICS INC | CORT | 1.73% |
WAVE LIFE SCIENCES LTD | WVE | 1.61% |
AMNEAL PHARMACEUTICALS INC | AMRX | 1.61% |
PACIRA BIOSCIENCES INC | PCRX | 1.58% |
JOHNSON + JOHNSON | JNJ | 1.57% |
INDIVIOR PHARMACEUTICALS INC | INDV | 1.57% |
SUPERNUS PHARMACEUTICALS INC | SUPN | 1.57% |
HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.56% |
ELANCO ANIMAL HEALTH INC | ELAN | 1.56% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.56% |
ELI LILLY + CO | LLY | 1.55% |
ROYALTY PHARMA PLC CL A | RPRX | 1.54% |
MERCK + CO. INC. | MRK | 1.52% |
TARSUS PHARMACEUTICALS INC | TARS | 1.52% |
BRISTOL MYERS SQUIBB CO | BMY | 1.51% |
VIATRIS INC | VTRS | 1.5% |
COLLEGIUM PHARMACEUTICAL INC | COLL | 1.49% |
ANI PHARMACEUTICALS INC | ANIP | 1.48% |
ESPERION THERAPEUTICS INC | ESPR | 1.47% |
AXSOME THERAPEUTICS INC | AXSM | 1.46% |
ORGANON + CO | OGN | 1.46% |
OMEROS CORP | OMER | 1.46% |
BIOAGE LABS INC | BIOA | 1.44% |
XERIS BIOPHARMA HOLDINGS INC | XERS | 1.44% |
PRESTIGE CONSUMER HEALTHCARE | PBH | 1.43% |
INNOVIVA INC | INVA | 1.4% |
RAPPORT THERAPEUTICS INC | RAPP | 1.38% |
PFIZER INC | PFE | 1.37% |
PERRIGO CO PLC | PRGO | 1.35% |
ZOETIS INC | ZTS | 1.34% |
ETON PHARMACEUTICALS INC | ETON | 1.28% |
PHIBRO ANIMAL HEALTH CORP A | PAHC | 1.26% |
ARVINAS INC | ARVN | 1.22% |
ALTO NEUROSCIENCE INC | ANRO | 1.16% |
ZEVRA THERAPEUTICS INC | ZVRA | 1.14% |
PHATHOM PHARMACEUTICALS INC | PHAT | 1.13% |
AMPHASTAR PHARMACEUTICALS IN | AMPH | 1.12% |
SEPTERNA INC | SEPN | 1.06% |
CORMEDIX INC | CRMD | 1.06% |
RELMADA THERAPEUTICS INC | RLMD | 0.94% |
ACLARIS THERAPEUTICS INC | ACRS | 0.92% |
THERAVANCE BIOPHARMA INC | TBPH | 0.91% |
LB PHARMACEUTICALS INC | LBRX | 0.79% |
AQUESTIVE THERAPEUTICS INC | AQST | 0.74% |
FULCRUM THERAPEUTICS INC | FULC | 0.64% |
LEXICON PHARMACEUTICALS INC | LXRX | 0.56% |
EVOLUS INC | EOLS | 0.49% |
SSI US GOV MONEY MARKET CLASS | SSI.US.GOV.MONEY.MARKET.CLASS | 0.06% |
US DOLLAR | US.DOLLAR | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
SPDR® S&P Pharmaceuticals ETF (XPH) share price today is $68.44.
Yes, Indians can buy shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. To buy XPH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. You can start investing in SPDR® S&P Pharmaceuticals ETF (XPH) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Pharmaceuticals ETF (XPH) is $70.15. The 52-week low price of SPDR® S&P Pharmaceuticals ETF (XPH) is $40.54.
The stock symbol (or ticker) of SPDR® S&P Pharmaceuticals ETF is XPH.
Yes, you can setup SIP in SPDR® S&P Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XPH on the Vested app.
The expense ratio of SPDR® S&P Pharmaceuticals ETF (XPH) is 0.35%.
Link copied